1 Jan 2014 Jahr - FDA approves two immunotherapies for melanoma
Beschreibung:
FDA grants accelerated approval to pembrolizumab and nivilumab for patients with advanced melanoma that can no longer be removed by surgery.
Zugefügt zum Band der Zeit:
Datum: